Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Infancy
  - AverageAgeOfOnset:
      value: Neonatal
  Childs:
  - Child:
      Genes: no data
      Label: Neu-Laxova syndrome
      ORPHAcode: '2671'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '10942'
            Source: HGNC
          - Reference: '600229'
            Source: OMIM
          Label: solute carrier family 1 member 4
          Symbol: SLC1A4
      Label: Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly
        syndrome
      ORPHAcode: '447997'
  - Child:
      Genes: no data
      Label: Serine biosynthesis pathway deficiency, infantile/juvenile form
      ORPHAcode: '583595'
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_557495
    value: Category
  Label: Neurometabolic disorder due to serine deficiency
  ORPHAcode: '35705'
  ORPHApacketId: '35705'
  PURL: http://www.orpha.net/ORDO/Orphanet_35705
  Parents:
  - Parent:
    - Label: Neurometabolic disease
      ORPHAcode: '68385'
  - Parent:
    - Label: Disorder of serine or glycine metabolism
      ORPHAcode: '79194'
  Prevalences:
  - Prevalence:
      PrevalenceClass: no data
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Case
      PrevalenceType: Cases/families
      Source: ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: ORPHANET
      ValMoy: no data
  Synonyms:
  - Synonym: Serine deficiency
  TextSection:
    Contents: 'Serine-deficiency syndrome is a very rare infantile-onset potentially
      treatable neurometabolic disorder characterized clinically by microcephaly neurodevelopmental
      disorders and seizures. Three serine-deficiency syndromes have been described:
      3-phosphoglycerate dehydrogenase (3-PGDH) deficiency 3-phosphoserine phosphatase
      (3-PSP) deficiency and phosphoserine aminotransferase deficiency (see these
      terms).'
    TextSectionType: Definition
  copyright: Orphanet (c) 2024
  creationDate: '2024-07-01 09:48:26'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
